10. Patients who have a condition requiring systemic treatment with corticosteroids (>10 mg daily prednisone equivalents) or other immunosuppressive medications within 14 days of study drug administration are not eligible. However, inhaled or topical steroids, adrenal replacement doses, and >10 mg daily prednisone equivalents are permitted in the absence of active autoimmune disease.